| ID | Name | CAS | Data |
MW (g/mol) |
| 51-266-0 |
1-Methyl-2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one
|
|
3 | 200.24 |
| 51-432-5 |
Cholanic acid, 3«beta»,7«alpha»,12«alpha»-trihydroxy, Me-TMS
|
|
3 | 639.14 |
| 51-590-0 |
1-Cyclopentadienyl-5-phenyl-1,1,3,3,5,5-hexamethyl trisiloxane
|
|
3 | 348.66 |
| 51-594-6 |
2-(2-(2-(2-(2-(2-(2-Pentoxy-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethyl TMS ether
|
|
3 | 512.76 |
| 51-610-7 |
5-Cholesten-3-«beta»,7-«alpha»,25,26-tetrol, TMS
|
|
3 | 723.38 |
| 51-638-7 |
Thiazolo[3,2-a]pyridinium, 2,3-dihydro-8-hydroxy-, hydroxide, inner salt
|
23003-45-4 |
3 | 153.20 |
| 51-692-7 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-pentyl-phosphorothioamidate
|
|
3 | 295.71 |
| 52-092-2 |
2-Ethyl-5,5-dimethyl-5-propionyl-1,3,4-oxadiazoline
|
|
3 | 184.24 |
| 52-103-9 |
N-(2-Furylmethyl)-N-tert-butyldimethylsilyl-9H-purin-6-amine
|
|
3 | 329.47 |
| 52-132-7 |
Propanoic acid, 3-[N-(2-formyl-5-methyl-1-pyrrolyl)]
|
|
3 | 181.19 |
| 52-159-8 |
1,6-Diazatetracyclo[4.3.27,9.12,5]dodecane
|
105090-34-4 |
3 | 164.25 |
| 52-331-6 |
R,S-4'-methyl-«alpha»-pyrrolidinohexanophenone-M (oxo-HO-toluol-), AC
|
|
3 | 331.41 |
| 52-425-2 |
1,3,5,2,4,6-Triazatriphosphorine, 2,2,4,4,6-pentabromo-6-chloro-2,2,4,4,6,6-hexahydro-
|
|
3 | 569.92 |
| 52-489-2 |
(3,5-BIS-CYANOMETHYL-[1,3,5]TRIAZINAN-1-YL)-ACETONITRILE
|
|
3 | 204.24 |
| 52-553-0 |
Thiazolo[3,2-c]pyrimidin-4-ium, 2,3-dihydro-8-hydroxy-5-methyl-, hydroxide, inner salt
|
|
3 | 168.22 |
| 52-726-8 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 5-butyl-2,6-dimethyl
|
|
3 | 224.31 |
| 52-806-9 |
R,S-4'-methyl-«alpha»-pyrrolidinohexanophenone-M (oxo-HO-alkyl-), AC
|
|
3 | 331.41 |
| 53-012-9 |
Propanoic acid, 3-[N-(2-formyl-5-(hydroxymethyl)-1-pyrrolyl)]
|
|
3 | 197.19 |
| 53-117-3 |
Valine-glutamine-tryptophan-leucine, N(«alpha»,«epsilon»)-trifluoroacetyl-N-O-permethyl derivative
|
|
3 | 834.86 |
| 53-221-7 |
2-Chloro-10-(3'-dimethylaminopropyl)-5,5-phenothiazinedioxide, hydrochloride, monohydrate
|
|
3 | 405.34 |
| 53-684-4 |
5-«alpha»-Pregnan-3-«beta»-15x-diol-20-one, TMS
|
|
3 | 478.86 |
| 53-784-3 |
1,3,5,2,4,6-Triazatriphosphorine, 2-bromo-2,4,4,6,6-pentachloro-2,2,4,4,6,6-hexahydro-
|
14740-93-3 |
3 | 392.11 |
| 53-798-8 |
Silane, dimethyldi(2,2,3,3,4,4,5,5-octafluoropentyloxy)-
|
|
3 | 520.28 |
| 53-802-2 |
Benzeneacetic acid, «alpha»-[[(trimethylsilyl)oxy]methyl]-, 9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2,4)]non-7-yl ester, [7(S)-(1«alpha»,2«beta»,4«beta»,5«alpha»,7«beta»)]-
|
55373-83-6 |
3 | 375.53 |
| 53-985-0 |
6-Chloro-N-sec-butyl-N'-heptafluorobutryl-1,3,5-triazine-2,4-diamine
|
|
3 | 397.68 |
| 54-026-3 |
2,6-Pyridinedicarboxylic acid, ethyl 1-methoxydec-4-yl ester
|
|
3 | 365.46 |
| 54-458-4 |
1,3,4-Oxadiazol-2(3h)-one, 3-acetyl-5-(5-nitro-2-furyl)-
|
|
3 | 239.14 |
| 54-560-0 |
2,3,5,6,7,8,9,10-Octahydro-1H-cycloocta[d]pyrrolo[1,2-a]pyrimidin-11-one
|
|
3 | 218.30 |
| 54-652-8 |
7H-pyrrolo[2,3-d]pyrimidine, 4-amino-7-[3-(hydroxymethyl)cyclopentyl]-
|
|
3 | 232.29 |
| 54-881-4 |
1,2,3,4,6,7,8,9,10,11-Decahydro-4a,12-diaza-cycloocta[b]naphthalen-5-one
|
|
3 | 232.32 |
| 55-093-8 |
5-Ethyl-5-methyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 156.18 |
| 55-233-2 |
4-Quinolinol,1-ethyl-4-ethynyldecahydro-2-methyl-(2«alpha»,4«alpha»,4a«alpha»,8a«beta»)
|
38463-54-6 |
3 | 221.34 |
| 55-267-5 |
2,3'-Bipyridine, 1'-acetyl-1',3,4,4',5,5',6,6'-octahydro-
|
|
3 | 206.29 |
| 55-320-5 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-butyl-phosphorothioamidate
|
|
3 | 295.71 |
| 55-372-8 |
4-Quinolinol,1,4-diethyldecahydro-2-methyl-(2«alpha»,4«alpha»,4a«beta»,8a«alpha»)
|
38463-62-6 |
3 | 225.37 |
| 55-407-9 |
2-Butenoic acid, 3-methyl-2-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
|
3 | 260.48 |
| 55-533-9 |
1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-
|
642-72-8 |
3 | 309.41 |
| 55-599-7 |
2(1H)-Pyridinone, 3-acetyl-4-hydroxy-1,6-dimethyl-
|
7202-55-3 |
3 | 181.19 |
| 55-862-4 |
5.beta.-Cholestane-3.alpha.,7.alpha.,26-triol, TMS
|
|
3 | 623.20 |
| 56-086-5 |
2,3-Dihydro-1H-4,8a-diaza-cyclopenta[b]naphthalen-9-one
|
|
3 | 186.21 |
| 56-112-5 |
5«beta»-Stigmastanol (24«beta»-ethyl-5«beta»-cholestan-3«beta»-ol), TMS
|
|
3 | 488.90 |
| 56-323-1 |
N-(1,2-Dimethylpropyl)-N,N'-bis(trifluoroacetyl)-N'-ethyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine
|
|
3 | 447.40 |
| 56-883-0 |
3-.beta.,7-.alpha.-Dihydroxy-5-cholenoic acid, methyl ester, TMS
|
|
3 | 548.96 |
| 57-058-5 |
3-[(Pyrrol1,1,3,3-tetramethyl-3-[(1-methylpentyl)oxy]disiloxanylmorphooxy)methyl]pyridine
|
|
3 | 341.59 |
| 57-084-6 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, heptyl ester
|
|
3 | 415.45 |
| 57-606-6 |
4-Quinolinol, 4-ethyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«beta»,8a«alpha»)-
|
20422-68-8 |
3 | 211.34 |
| 57-634-5 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»,25-diol, DMESI
|
|
3 | 605.14 |
| 57-713-7 |
Trimethylsilyl 2-[(3,5,6-trichloro-2-pyridyl)oxy]acetate
|
|
3 | 328.65 |
| 57-805-5 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6-methyl
|
|
3 | 160.17 |
| 57-831-6 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, nonyl ester
|
|
3 | 495.50 |
| 57-900-9 |
4-(tert-Butylamino)-6-ethyl-6-trifluoroacetylamino-5H-1,3,5-triazin-2-one
|
|
3 | 307.27 |
| 57-905-4 |
Cholanic acid, 3«beta»,7«beta»,12«alpha»-trihydroxy, Me-TMS
|
|
3 | 639.14 |
| 57-930-6 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-cyclopropyl-phosphorothioamidate
|
|
3 | 265.65 |
| 58-050-2 |
3-oxy-7«alpha»-hydroxy-4-cholestenoate, methyl ester-trimethylsilyl ether
|
|
3 | 589.01 |
| 58-110-5 |
5«beta»-Androstane-3«beta»,17«beta»-diol,bis-TMS
|
|
3 | 436.82 |
| 58-249-2 |
4H-Cyclopenteno[2,3-e]pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 7-methyl
|
|
3 | 200.24 |
| 58-457-1 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-propyl-phosphorothioamidate
|
|
3 | 267.66 |
| 58-480-5 |
5-«alpha»-Androstan-3-«beta»-ol-17-«beta»-carboxylate, MeTMS
|
|
3 | 406.67 |
| 58-508-4 |
3,17-Bis[(trimethylsilyl)oxy]-5«beta»-androstane, (3«beta»,17«beta»)-
|
18880-48-3 |
3 | 436.82 |
| 58-624-5 |
2,6-Pyridinedicarboxylic acid, di(2,4,4-trimethylpentyl) ester
|
|
3 | 391.54 |
| 58-638-0 |
2,5-Diethyl-5-methyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 184.24 |
| 58-811-7 |
24-Nor-5.beta.-cholestane-3.alpha.,7.alpha.,25-triol, TMS
|
|
3 | 623.20 |
| 58-886-5 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 8-methyl
|
|
3 | 164.21 |
| 59-007-9 |
4H-Cyclopenteno[2,3-e]pyrido[1,2-a]pyrimidin-4-one, 9-methyl
|
|
3 | 200.24 |
| 59-082-6 |
5-Pregnen-3«beta»,17«alpha»,20«alpha»-triol, (VDMS)2
|
|
3 | 502.88 |
| 59-126-7 |
1,3,2-Diazaphosphol-4-ene, 2-(diethylamino)-1,3-dibutyl-4,5-dimethyl-
|
141968-98-1 |
3 | 299.44 |
| 59-134-8 |
5-Androstene-3-«beta»,15-«alpha»,16-«alpha»,17-«beta»-tetrol, TMS
|
|
3 | 611.16 |
| 59-367-0 |
Cholanic acid, 3«beta»,7«beta»,12«beta»-trihydroxy, Me-DMES
|
|
3 | 681.22 |
| 59-804-4 |
benzaldehyde oxime, 2-hydroxy, 3-nitro, 5-(1,1,3,3-tetramethylbutyl)
|
|
3 | 294.35 |
| 59-894-5 |
2,6-Pyridinedicarboxylic acid, 2-methylhex-3-yl 4-octyl ester
|
|
3 | 377.52 |
| 59-897-2 |
5,5-Diethyl-2-(1-methylethyl)-4-isobutanoyl-1,3,4-oxadiazoline
|
|
3 | 240.34 |
| 60-181-4 |
1H-1,2,4-Triazole, 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]-
|
112281-77-3 |
3 | 372.15 |
| 60-377-7 |
4-Quinolinol,4-ethenyl-1-ethyldecahydro-2-methyl-(2«alpha»,4«alpha»,4a«beta»,8a«alpha»
|
38463-59-1 |
3 | 223.35 |
| 60-519-9 |
1H-Imidazole, 1-(2,2,3,3,3-pentafluoro-1-oxopropyl)-
|
71735-32-5 |
3 | 214.09 |
| 60-576-6 |
L-Tryptophan, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
3 | 418.49 |
| 60-608-0 |
2-Octalen-1-one, 3,4a,8,8-tetramethyl, 4-(2-(3-furyl)ethyl))
|
|
3 | 300.44 |
| 60-814-1 |
[(1R,8R)-7-(Hydroxymethyl)-2,3,5,8-tetrahydro-1H-pyrrolizin-1-yl] (E)-4-hydroxy-3-methyl-but-2-enoate
|
|
3 | 267.32 |
| 60-877-2 |
5-Ethyl-2,5-dimethyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 170.21 |
| 60-925-8 |
2,6-Pyridinedicarboxylic acid, 5-methoxy-3-methylpent-2-yl propyl ester
|
|
3 | 323.39 |
| 60-927-6 |
Pyrrolidino[1,2-e]-4H-1,3,5-dithiazine, 4-methyl-2-(2-methylpropyl)
|
|
3 | 231.42 |
| 60-952-8 |
1-[3,4-methylenedioxy-benzyl]piperazine -M, (desmethylen-methyl-), 2AC
|
|
3 | 306.36 |
| 61-249-8 |
5H-Dibenz[c,e]azepine, 6,7-dihydro-6-(2-propenyl)-
|
146-36-1 |
3 | 235.32 |
| 61-408-1 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, propyl ester
|
|
3 | 325.35 |
| 61-543-1 |
Ergostanol (24«alpha»-methyl-5«alpha»-cholestan-3«beta»-ol), TMS
|
|
3 | 474.88 |
| 61-685-4 |
3,9-Diazaoctacyclo[9.3.22,10.0.03,9.04,8.05,15.07,16]tetradecane
|
|
3 | 214.31 |
| 61-842-9 |
5-Ethyl-5-methyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 170.21 |
| 61-932-9 |
«alpha»-D-Glucopyranose, 1,2,3,4,6-pentakis-O-(trimethylsilyl)-
|
3327-61-5 |
3 | 541.06 |
| 62-108-3 |
3-«alpha»,6-«alpha»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
3 | 639.14 |
| 62-117-3 |
1,3-Disiloxane, 1,3-diethoxy, 1,3-bis-(2-propenyl), 1,3-bis-(chloromethyl)
|
|
3 | 343.39 |
| 62-379-3 |
N-tert-Butyl-N-trifluoroacetyl-N'-trifluoroacetyl-N'-cyclopropyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine
|
|
3 | 445.38 |
| 62-390-0 |
7H-Furo[3,2-g][1]benzopyran-7-one, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (S)-
|
13849-08-6 |
3 | 246.26 |
| 62-401-7 |
5-[2-(4-Allyl-2,6-dimethoxy-phenoxy)-1-hydroxy-propyl]-2-methoxy-phenol, TES
|
|
3 | 586.95 |
| 62-445-9 |
O-(2-Chloroethyl)-O-(1,1-difluoro-2-chloroethyl)-phosphorothiochloridate
|
|
3 | 293.49 |
| 62-451-2 |
6,7,8,9,10,11-Hexahydro-5,11a-diaza -cycloocta[b]naphthalen-12-one
|
|
3 | 228.29 |
| 62-526-9 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 2-methyl
|
|
3 | 164.21 |
| 62-903-0 |
1,5,6-Triazabicyclo[3.1.0]hexane, 4,4-dimethyl-2,2,6-tris(trifluoromethyl)-
|
95388-86-6 |
3 | 317.15 |
| 62-967-0 |
2,3-Dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one
|
|
3 | 186.21 |
| 63-017-3 |
1,3,5,7-Tetramethyl-1,3,5,7-tetravinylcyclotetrasiloxane
|
|
3 | 344.66 |
| 63-024-5 |
Phosphorothioic acid, O-(6-ethoxy-2-ethyl-4-pyrimidinyl) O,O-dimethyl ester
|
38260-54-7 |
3 | 292.29 |
| 63-058-8 |
4-Quinolinol,1,4-diethyldecahydro-2-methyl-(2«alpha»,4«alpha»,4a«alpha»,8a«beta»
|
38463-60-4 |
3 | 225.37 |
|
« Previous Results
Next Results »
|